Myasthenia Gravis and Acetylcholine Receptor-Antibodies. AChR-Antibodies as a Marker for Epidemiological Studies and in the Follow-up of Patients
Has parts
Paper I: Heldal AT, Owe JF, Gilhus NE, Romi F. Seropositive myasthenia gravis: A nationwide epidemiologic study. Neurology. 2009 Jul 14;73(2): 150-1. The article is not available in BORA due to publisher restrictions. The published version is available at: http://dx.doi.org/10.1212/wnl.0b013e3181ad53c2Paper II: Heldal AT, Eide GE, Gilhus NE, Romi F. Geographical distribution of a seropositive myasthenia gravis population. Muscle Nerve. 2012 Jun; 45(6):815- 9. The article is not available in BORA due to publisher restrictions. The published version is available at: http://dx.doi.org/10.1002/mus.23271
Paper III: Andersen JB, Heldal AT, Engeland A, Gilhus NE. Myasthenia gravis epidemiology in a national cohort; combining multiple disease registries. Acta neurologica Scandinavica Supplementum. 2014: 26-31. The article is not available in BORA due to publisher restrictions. The published version is available at: http://dx.doi.org/10.1111/ane.12233
Paper IV: Heldal AT, Eide GE, Romi F, Owe JF, Gilhus NE. Acetylcholine receptor antibody-concentration and association to myasthenia gravis development. The article is not available in BORA.